Neuroendocrine changes in depression. - Wikidata - awgldk - TriplyDB

Neuroendocrine changes in depression.

Neuroendocrine changes in depression.

http://www.wikidata.org/entity/Q38153758

about

Presence of Anxiety and Depression Symptoms Affects the First Time Treatment Efficacy and Recurrence of Benign Paroxysmal Positional Vertigo.

P2860

Q52606177-CC43D9C3-87CA-4286-80A2-47FC06E56429

P2860

Neuroendocrine changes in depression.

http://www.wikidata.org/entity/Q38153758

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Neuroendocrine changes in depression.

@en

type

label

Neuroendocrine changes in depression.

@en

prefLabel

Neuroendocrine changes in depression.

@en

P1433

Q38153758-58510B97-7A76-4DEA-93C7-DA0A7EEFBA82

P1476

Q38153758-A089EEF0-0413-4633-B929-96B6489EE054

P2093

Q38153758-6089534E-EA5E-4C6D-9227-BB8302A04B0B

P2860

Q38153758-005DD715-3944-48F1-92FE-AF6266888731

Q38153758-0592B36E-3FA0-46F2-A442-CD85F203157D

Q38153758-07A82DC8-2B43-489D-9608-170C9354F347

Q38153758-07F5185D-A06B-4831-B7B0-1AFD59926E17

Q38153758-0AE7C39D-0642-4178-BFC2-1408CDB792DE

Q38153758-119F87A6-D2EA-47FD-AACF-78280D22D1A2

Q38153758-11C2ED19-B436-48AA-A446-34947BE4CFE1

Q38153758-15D6D9E9-E1FE-4B0B-BCDB-A6870C4820F0

Q38153758-1B6714C7-12C0-49F6-A367-A6F92E81FEFA

Q38153758-27848FF4-7265-4064-A270-AFBFC0D12628

P304

Q38153758-F8DE6154-0F4B-4C08-B718-6F0D5307093E

P31

Q38153758-E14B733F-470D-4005-B86F-AEF4FF02DD0C

P356

Q38153758-99E27EB1-AAF0-4A49-8111-04FD18F7200B

P433

Q38153758-801D0DE3-2628-43C3-BCCB-C274E40ABD0A

P478

Q38153758-3F2D7279-1853-48BD-B9F2-04431DD52318

P577

Q38153758-52D6E751-DD62-49B6-98B9-256335CD95F5

P698

Q38153758-1986EC73-2DD3-47E4-900F-196BC6286516

P356

00048678509161309

P1433

Australian and New Zealand Journal of Psychiatry

P1476

Neuroendocrine changes in depression.

@en

P2093

P R Joyce

http://www.w3.org/2001/XMLSchema#string

P2860

Psychoneuroendocrinology of affective disorder: an overview.

Clinical and biochemical heterogeneity of depressive disorders.

Neuroendocrine and amine studies in affective illness.

A clinical and biochemical study of a trial of iproniazid in the treatment of depression.

Vasopressin in affective illness.

Thyrotrophin-releasing hormone (TRH) stimulation test in manic-depressive illness.

Central monoamine metabolism in depressions. I. Serotonin and related compounds.

Receptor adaptations to centrally acting drugs.

Dysthymic disorder: psychopathology of proposed chronic depressive subtypes.

Cortisol determination and the dexamethasone suppression test. A review.

P304

120-127

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/00048678509161309

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

1985-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

2413836

http://www.w3.org/2001/XMLSchema#string